表 2. Test results of T cell subsets in the three groups at baseline (
).
入组时3组对象T淋巴细胞亚群检测结果（
）
| Item | Deficiency group (n=76) | Recovery group (n=61) | Control group (n=22) | F | P |
| a P<0.05, vs. control group; b P<0.05, vs. recovery group. | |||||
| CD4+HLA-DR+CD38+(%) | 13.27±8.44a, b | 7.95±6.13 | 4.95±2.24 | 16.51 | <0.001 |
| CD8+HLA-DR+CD38+(%) | 18.34±9.68a, b | 13.63±9.47 | 11.23±7.39 | 7.05 | 0.001 |
| CD4+CD57+CD28−(%) | 9.76±10.45 | 9.96±10.49 | 5.85±7.55 | 1.49 | 0.229 |
| CD8+CD57+CD28−(%) | 35.61±14.29a | 35.45±14.30a | 26.40±13.20 | 3.95 | 0.021 |
| CD4+CD45RA−CD27−(%) | 21.97±10.35a | 19.71±12.44 | 15.63±5.09 | 3.10 | 0.048 |
| CD8+CD45RA−CD27−(%) | 28.35±13.27a | 25.25±13.61a | 16.95±8.25 | 6.75 | 0.002 |
| CD4+CD45RA−CD27+(%) | 43.23±9.73a, b | 35.74±9.48a | 53.38±10.40 | 28.26 | <0.001 |
| CD8+CD45RA−CD27+(%) | 21.17±8.49a | 20.63±9.40a | 28.31±11.36 | 6.06 | 0.003 |
| CD4+CD45RA+CD27+(%) | 31.52±13.77b | 41.41±14.26a | 28.14±8.49 | 12.44 | <0.001 |
| CD8+CD45RA+CD27+(%) | 20.47±12.52a | 24.82±13.50a | 32.62±13.21 | 7.75 | 0.001 |